Literature DB >> 2675005

Long-term follow-up in superficial transitional cell carcinoma of the bladder: prognostic factors for time to first recurrence, recurrence rate, and survival. Final results of a randomized trial comparing doxorubicin hydrochloride, ethoglucid, and transurethral resection alone. EORTC Genitourinary Tract Cancer Cooperative Group.

K Kurth1, F H Schroeder, F Debruyne, T Senge, M Pavone-Macaluso, M de Pauw, F ten Kate, R Sylvester.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2675005

Source DB:  PubMed          Journal:  Prog Clin Biol Res        ISSN： 0361-7742


× No keyword cloud information.
  2 in total

Review 1.  Handling and pathology reporting of specimens with carcinoma of the urinary bladder, ureter, and renal pelvis. A joint proposal of the European Society of Uropathology and the Uropathology Working Group.

Authors:  Antonio Lopez-Beltran; Pier Francesco Bassi; Michele Pavone-Macaluso; Rodolfo Montironi
Journal:  Virchows Arch       Date:  2004-06-08       Impact factor: 4.064

2.  Prospective randomized study of prophylaxis of superficial bladder cancer with epirubicin: the role of a central pathology laboratory. Nara Uro-oncology Research Group. (NUORG).

Authors:  Y Hirao; S Ozono; H Momose; E Okajima; T Hiramatsu; K Yoshida; S Fukushima; Y Ohashi
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.